LLY

1,043.27

-0.6%↓

JNJ

203.34

+0.48%↑

ABBV

229.85

-0.59%↓

UNH

313.29

+1.59%↑

AZN

88.75

0%↓

LLY

1,043.27

-0.6%↓

JNJ

203.34

+0.48%↑

ABBV

229.85

-0.59%↓

UNH

313.29

+1.59%↑

AZN

88.75

0%↓

LLY

1,043.27

-0.6%↓

JNJ

203.34

+0.48%↑

ABBV

229.85

-0.59%↓

UNH

313.29

+1.59%↑

AZN

88.75

0%↓

LLY

1,043.27

-0.6%↓

JNJ

203.34

+0.48%↑

ABBV

229.85

-0.59%↓

UNH

313.29

+1.59%↑

AZN

88.75

0%↓

LLY

1,043.27

-0.6%↓

JNJ

203.34

+0.48%↑

ABBV

229.85

-0.59%↓

UNH

313.29

+1.59%↑

AZN

88.75

0%↓

Search

Cencora Inc

Open

SectorHealthcare

362.72 0.44

Overview

Share price change

24h

Current

Min

359

Max

362.89

Key metrics

By Trading Economics

Income

-1B

-340M

Sales

3.1B

84B

P/E

Sector Avg

45.854

106.172

EPS

3.84

Dividend yield

0.61

Profit margin

-0.406

Employees

51,000

EBITDA

-1.1B

150M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+8.89% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.61%

2.31%

Next Dividend date

1 gru 2025

Market Stats

By TradingEconomics

Market Cap

4.7B

71B

Previous open

362.28

Previous close

362.72

News Sentiment

By Acuity

34%

66%

102 / 374 Ranking in Healthcare

Cencora Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

19 lis 2025, 23:36 UTC

Hot Stocks

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

19 lis 2025, 22:13 UTC

Earnings
Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

19 lis 2025, 21:55 UTC

Major Market Movers

Amgen Lung Cancer Drug Gets Full Approval From FDA

19 lis 2025, 21:43 UTC

Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

19 lis 2025, 23:55 UTC

Market Talk

Gold Rises on Possible Investment Demand -- Market Talk

19 lis 2025, 23:54 UTC

Market Talk

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

19 lis 2025, 23:47 UTC

Earnings

Lenovo Group 2Q EPS $2.52 >0992.HK

19 lis 2025, 23:46 UTC

Earnings

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

19 lis 2025, 23:45 UTC

Earnings

Lenovo Group 2Q Rev $20.5B >0992.HK

19 lis 2025, 23:42 UTC

Market Talk

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

19 lis 2025, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

19 lis 2025, 23:41 UTC

Earnings

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

19 lis 2025, 23:41 UTC

Earnings

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

19 lis 2025, 23:40 UTC

Earnings

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

19 lis 2025, 22:55 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

19 lis 2025, 22:41 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

19 lis 2025, 22:30 UTC

Acquisitions, Mergers, Takeovers

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

19 lis 2025, 22:30 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

19 lis 2025, 22:30 UTC

Acquisitions, Mergers, Takeovers

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

19 lis 2025, 22:27 UTC

Acquisitions, Mergers, Takeovers

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

19 lis 2025, 22:08 UTC

Earnings

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

19 lis 2025, 22:00 UTC

Earnings

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

19 lis 2025, 21:58 UTC

Earnings
Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

19 lis 2025, 21:52 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

19 lis 2025, 21:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

19 lis 2025, 21:49 UTC

Market Talk
Earnings

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

19 lis 2025, 21:38 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

19 lis 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35B

19 lis 2025, 21:27 UTC

Acquisitions, Mergers, Takeovers

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

19 lis 2025, 21:24 UTC

Earnings
Acquisitions, Mergers, Takeovers

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Peer Comparison

Price change

Cencora Inc Forecast

Price Target

By TipRanks

8.89% upside

12 Months Forecast

Average 393.78 USD  8.89%

High 417 USD

Low 361 USD

Based on 10 Wall Street analysts offering 12 month price targets forCencora Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

9

Buy

1

Hold

0

Sell

Sentiment

By Acuity

102 / 374 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat